Clinical Trial Update: Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing PRO-157 (pazufloxacin) to moxifloxacin and gatifloxacin for bacterial conjunctivitis has completed with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• Gatifloxacin (Gatifloxacin)
• Moxifloxacin (moxifloxacin)
• PRO-157 (pazufloxacin)

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Bacterial Conjunctivitis | Phase 2 | Status: COMPLETED | Results posted: 2019-02-15